Share Price and Basic Stock Data
Last Updated: January 23, 2026, 9:53 pm
| PEG Ratio | 2.39 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Axel Polymers Ltd operates within the plastics industry, focusing on the production of plastic and plastic products. The company has demonstrated a strong upward trajectory in its revenue, with reported sales rising from ₹5.56 Cr in March 2014 to ₹82.65 Cr in March 2023. The latest reported sales for the trailing twelve months (TTM) stood at ₹47.86 Cr. In the quarterly breakdown, the company recorded a sales increase to ₹30.92 Cr in September 2023, followed by a significant jump to ₹38.65 Cr in December 2023. This consistent revenue growth highlights the company’s ability to capture market demand effectively. However, the sales for March 2025 are expected to decline to ₹78.09 Cr, indicating potential fluctuations in demand. The operating profit margin (OPM) has been volatile, peaking at 23.03% in March 2025 but showing a downward trend in recent quarters, reflecting the need for better cost management as expenses have also risen sharply.
Profitability and Efficiency Metrics
In terms of profitability, Axel Polymers reported a net profit of ₹1.52 Cr, with a return on equity (ROE) of 1.13% and a return on capital employed (ROCE) of 7.88%. The company’s operating profit for the most recent quarter stood at ₹1.39 Cr, reflecting a decline in OPM to 4.50% in September 2023. The interest coverage ratio (ICR) is at 1.27x, indicating that the company generates enough earnings to cover its interest obligations, though the margin is thin. The cash conversion cycle (CCC) reported at 175.64 days suggests inefficiencies in managing working capital, particularly in accounts receivable and inventory days. While the company has shown some resilience in profitability, the fluctuating profit margins and extended cash conversion cycle present challenges that need to be addressed to enhance overall efficiency.
Balance Sheet Strength and Financial Ratios
Axel Polymers’ balance sheet reflects a total borrowings figure of ₹31.82 Cr, against reserves of ₹6.71 Cr, indicating a high debt-to-equity ratio of 2.25x. This substantial leverage may pose risks, especially in a tightening credit environment. The book value per share has increased to ₹17.77 in March 2025, up from ₹15.89 in March 2023, suggesting some strengthening of the company’s equity base. However, the current ratio of 1.19x indicates that the company barely meets its short-term liabilities, while the quick ratio of 0.32x raises concerns about liquidity. Additionally, the interest coverage ratio of 1.27x suggests that while the company can meet its interest obligations, it does so with limited buffer. The enterprise value (EV) of ₹66.75 Cr indicates a valuation that may require careful scrutiny in the context of its operational performance and financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Axel Polymers reveals that promoters hold 61.16% of the equity, reflecting strong insider confidence in the company’s prospects. The public holds a significant 38.61%, while domestic institutional investors (DIIs) account for a mere 0.24%. The total number of shareholders stood at 10,067 as of September 2025, indicating a relatively stable shareholder base. The low foreign institutional investment (FIIs) presence suggests potential challenges in attracting broader institutional interest, which may be a factor in the stock’s liquidity. The gradual decline in promoter holdings from 61.90% in December 2022 to the current level may raise questions about future governance and control. However, the consistent public holding indicates a degree of investor trust, which could be pivotal for future capital raises and strategic initiatives.
Outlook, Risks, and Final Insight
Looking forward, Axel Polymers faces both opportunities and challenges. The continued growth in revenue signals a positive market demand for its products, but the decline in profitability metrics and extended cash conversion cycle highlight operational inefficiencies that need addressing. The high debt levels pose a risk, particularly in a fluctuating economic environment, as they may constrain financial flexibility. Additionally, with a low institutional investor presence, the company may struggle with liquidity and market perception. Strengths include a strong promoter holding, suggesting confidence in the company’s long-term strategy, and a robust increase in sales. Risks include potential cash flow issues due to extended CCC and high leverage. To enhance its market position, Axel Polymers should focus on improving operational efficiencies and managing its debt more effectively, which could lead to a more favorable investment outlook in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mitsu Chem Plast Ltd | 135 Cr. | 99.6 | 128/83.2 | 16.5 | 73.6 | 0.20 % | 10.4 % | 8.17 % | 10.0 |
| IIRM Holdings India Ltd | 599 Cr. | 87.8 | 120/68.0 | 32.6 | 21.3 | 0.00 % | 23.5 % | 18.6 % | 5.00 |
| Fiberweb (India) Ltd | 91.4 Cr. | 31.8 | 59.4/31.2 | 5.65 | 63.9 | 0.00 % | 10.0 % | 8.88 % | 10.0 |
| Deep Polymers Ltd | 91.4 Cr. | 37.8 | 69.9/35.0 | 18.4 | 37.5 | 0.00 % | 8.22 % | 6.10 % | 10.0 |
| DDev Plastiks Industries Ltd | 3,052 Cr. | 295 | 360/213 | 15.4 | 88.5 | 0.59 % | 33.9 % | 24.9 % | 1.00 |
| Industry Average | 1,590.18 Cr | 418.04 | 32.09 | 183.42 | 0.35% | 16.30% | 12.17% | 8.25 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.45 | 17.74 | 27.18 | 25.81 | 30.92 | 38.65 | 37.28 | 42.24 | 13.87 | 11.11 | 14.33 | 11.70 | 10.72 |
| Expenses | 20.42 | 16.58 | 25.29 | 24.28 | 29.53 | 37.18 | 35.85 | 41.93 | 13.72 | 10.95 | 11.03 | 10.70 | 9.79 |
| Operating Profit | 1.03 | 1.16 | 1.89 | 1.53 | 1.39 | 1.47 | 1.43 | 0.31 | 0.15 | 0.16 | 3.30 | 1.00 | 0.93 |
| OPM % | 4.80% | 6.54% | 6.95% | 5.93% | 4.50% | 3.80% | 3.84% | 0.73% | 1.08% | 1.44% | 23.03% | 8.55% | 8.68% |
| Other Income | 0.08 | 0.03 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.09 | 0.01 | 0.02 |
| Interest | 0.76 | 0.82 | 0.86 | 0.80 | 0.78 | 0.67 | 0.62 | 0.75 | 0.85 | 0.81 | 0.82 | 0.82 | 0.79 |
| Depreciation | 0.10 | 0.10 | 0.24 | 0.12 | 0.12 | 0.12 | 0.34 | 0.12 | 0.12 | 0.12 | 0.20 | 0.15 | 0.15 |
| Profit before tax | 0.25 | 0.27 | 0.91 | 0.62 | 0.50 | 0.69 | 0.48 | -0.53 | -0.81 | -0.76 | 2.37 | 0.04 | 0.01 |
| Tax % | 0.00% | 0.00% | 54.95% | 0.00% | 0.00% | 2.90% | 114.58% | 0.00% | 0.00% | 0.00% | 5.91% | 0.00% | 0.00% |
| Net Profit | 0.25 | 0.27 | 0.41 | 0.62 | 0.50 | 0.67 | -0.07 | -0.53 | -0.81 | -0.76 | 2.23 | 0.04 | 0.01 |
| EPS in Rs | 0.29 | 0.32 | 0.48 | 0.73 | 0.59 | 0.79 | -0.08 | -0.62 | -0.95 | -0.89 | 2.62 | 0.05 | 0.01 |
Last Updated: December 27, 2025, 11:05 pm
Below is a detailed analysis of the quarterly data for Axel Polymers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 10.72 Cr.. The value appears to be declining and may need further review. It has decreased from 11.70 Cr. (Jun 2025) to 10.72 Cr., marking a decrease of 0.98 Cr..
- For Expenses, as of Sep 2025, the value is 9.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.70 Cr. (Jun 2025) to 9.79 Cr., marking a decrease of 0.91 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.93 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Jun 2025) to 0.93 Cr., marking a decrease of 0.07 Cr..
- For OPM %, as of Sep 2025, the value is 8.68%. The value appears strong and on an upward trend. It has increased from 8.55% (Jun 2025) to 8.68%, marking an increase of 0.13%.
- For Other Income, as of Sep 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Jun 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.82 Cr. (Jun 2025) to 0.79 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Sep 2025, the value is 0.15 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Jun 2025) to 0.01 Cr., marking a decrease of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Jun 2025) to 0.01 Cr., marking a decrease of 0.03 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.01. The value appears to be declining and may need further review. It has decreased from 0.05 (Jun 2025) to 0.01, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:08 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.56 | 16.19 | 18.53 | 21.94 | 26.97 | 24.37 | 22.90 | 48.32 | 72.91 | 82.65 | 127.92 | 78.09 | 47.86 |
| Expenses | 6.05 | 14.74 | 17.37 | 20.81 | 25.65 | 22.71 | 21.51 | 44.41 | 68.80 | 77.53 | 122.12 | 74.13 | 42.47 |
| Operating Profit | -0.49 | 1.45 | 1.16 | 1.13 | 1.32 | 1.66 | 1.39 | 3.91 | 4.11 | 5.12 | 5.80 | 3.96 | 5.39 |
| OPM % | -8.81% | 8.96% | 6.26% | 5.15% | 4.89% | 6.81% | 6.07% | 8.09% | 5.64% | 6.19% | 4.53% | 5.07% | 11.26% |
| Other Income | 0.03 | 0.04 | 0.08 | 0.27 | 0.04 | 0.02 | 0.02 | 0.40 | 0.55 | 0.28 | 0.04 | 0.14 | 0.13 |
| Interest | 0.87 | 0.88 | 0.84 | 0.93 | 0.79 | 0.91 | 0.97 | 3.32 | 2.84 | 3.16 | 2.85 | 3.23 | 3.24 |
| Depreciation | 0.45 | 0.48 | 0.25 | 0.21 | 0.28 | 0.33 | 0.36 | 0.42 | 0.48 | 0.54 | 0.70 | 0.56 | 0.62 |
| Profit before tax | -1.78 | 0.13 | 0.15 | 0.26 | 0.29 | 0.44 | 0.08 | 0.57 | 1.34 | 1.70 | 2.29 | 0.31 | 1.66 |
| Tax % | 0.00% | 0.00% | 0.00% | 15.38% | 17.24% | -6.82% | -12.50% | -15.79% | 31.34% | 30.59% | 31.88% | 41.94% | |
| Net Profit | -1.78 | 0.12 | 0.15 | 0.22 | 0.23 | 0.47 | 0.09 | 0.66 | 0.92 | 1.18 | 1.56 | 0.17 | 1.52 |
| EPS in Rs | -4.14 | 0.28 | 0.35 | 0.51 | 0.53 | 1.09 | 0.21 | 1.53 | 1.08 | 1.39 | 1.83 | 0.20 | 1.79 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 106.74% | 25.00% | 46.67% | 4.55% | 104.35% | -80.85% | 633.33% | 39.39% | 28.26% | 32.20% | -89.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -81.74% | 21.67% | -42.12% | 99.80% | -185.20% | 714.18% | -593.94% | -11.13% | 3.94% | -121.31% |
Axel Polymers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 2% |
| TTM: | -66% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | -43% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 40% |
| 3 Years: | 8% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 7% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:31 pm
Balance Sheet
Last Updated: January 7, 2026, 5:03 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 |
| Reserves | -3.31 | -3.44 | -3.29 | -3.09 | -2.84 | -2.37 | -2.31 | 2.90 | 3.81 | 5.01 | 6.47 | 6.62 | 6.71 |
| Borrowings | 5.00 | 4.38 | 5.46 | 5.69 | 7.46 | 7.55 | 7.46 | 25.90 | 25.94 | 25.19 | 25.67 | 34.08 | 31.82 |
| Other Liabilities | 3.98 | 10.22 | 6.66 | 6.96 | 6.30 | 5.06 | 6.86 | 14.25 | 17.09 | 16.50 | 23.56 | 18.20 | 19.04 |
| Total Liabilities | 9.97 | 15.46 | 13.13 | 13.86 | 15.22 | 14.54 | 16.31 | 51.57 | 55.36 | 55.22 | 64.22 | 67.42 | 66.09 |
| Fixed Assets | 3.72 | 3.03 | 2.81 | 3.50 | 3.60 | 3.86 | 3.66 | 7.83 | 7.71 | 8.84 | 9.77 | 10.18 | 10.06 |
| CWIP | 0.30 | 0.30 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Other Assets | 5.95 | 12.13 | 10.31 | 10.36 | 11.62 | 10.68 | 12.65 | 43.74 | 47.65 | 46.38 | 54.45 | 57.24 | 56.03 |
| Total Assets | 9.97 | 15.46 | 13.13 | 13.86 | 15.22 | 14.54 | 16.31 | 51.57 | 55.36 | 55.22 | 64.22 | 67.42 | 66.09 |
Below is a detailed analysis of the balance sheet data for Axel Polymers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.52 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.52 Cr..
- For Reserves, as of Sep 2025, the value is 6.71 Cr.. The value appears strong and on an upward trend. It has increased from 6.62 Cr. (Mar 2025) to 6.71 Cr., marking an increase of 0.09 Cr..
- For Borrowings, as of Sep 2025, the value is 31.82 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 34.08 Cr. (Mar 2025) to 31.82 Cr., marking a decrease of 2.26 Cr..
- For Other Liabilities, as of Sep 2025, the value is 19.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.20 Cr. (Mar 2025) to 19.04 Cr., marking an increase of 0.84 Cr..
- For Total Liabilities, as of Sep 2025, the value is 66.09 Cr.. The value appears to be improving (decreasing). It has decreased from 67.42 Cr. (Mar 2025) to 66.09 Cr., marking a decrease of 1.33 Cr..
- For Fixed Assets, as of Sep 2025, the value is 10.06 Cr.. The value appears to be declining and may need further review. It has decreased from 10.18 Cr. (Mar 2025) to 10.06 Cr., marking a decrease of 0.12 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 56.03 Cr.. The value appears to be declining and may need further review. It has decreased from 57.24 Cr. (Mar 2025) to 56.03 Cr., marking a decrease of 1.21 Cr..
- For Total Assets, as of Sep 2025, the value is 66.09 Cr.. The value appears to be declining and may need further review. It has decreased from 67.42 Cr. (Mar 2025) to 66.09 Cr., marking a decrease of 1.33 Cr..
However, the Borrowings (31.82 Cr.) are higher than the Reserves (6.71 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.49 | -2.93 | -4.30 | -4.56 | -6.14 | -5.89 | -6.07 | -21.99 | -21.83 | -20.07 | -19.87 | -30.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 158.87 | 123.32 | 86.08 | 33.94 | 36.68 | 26.36 | 33.47 | 100.01 | 57.02 | 33.87 | 31.19 | 51.56 |
| Inventory Days | 130.41 | 127.01 | 102.73 | 123.25 | 113.12 | 146.24 | 184.09 | 218.96 | 166.83 | 168.33 | 125.70 | 215.52 |
| Days Payable | 180.68 | 175.90 | 38.81 | 36.63 | 19.49 | 20.20 | 62.21 | 125.81 | 95.43 | 80.23 | 71.47 | 91.43 |
| Cash Conversion Cycle | 108.60 | 74.43 | 150.00 | 120.56 | 130.30 | 152.40 | 155.35 | 193.16 | 128.43 | 121.97 | 85.42 | 175.64 |
| Working Capital Days | -115.54 | 4.51 | 47.27 | 12.48 | 20.71 | 13.33 | 18.33 | 33.16 | 27.78 | 30.74 | 24.77 | 29.87 |
| ROCE % | -12.36% | 17.99% | 16.91% | 17.35% | 13.65% | 14.67% | 11.09% | 16.63% | 11.06% | 12.63% | 12.95% | 7.88% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Diluted EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Cash EPS (Rs.) | 0.86 | 2.65 | 2.02 | 1.64 | 1.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Revenue From Operations / Share (Rs.) | 91.68 | 150.19 | 100.02 | 85.61 | 53.58 |
| PBDIT / Share (Rs.) | 4.82 | 6.84 | 6.34 | 5.48 | 3.74 |
| PBIT / Share (Rs.) | 4.16 | 6.02 | 5.70 | 4.91 | 2.88 |
| PBT / Share (Rs.) | 0.36 | 2.68 | 2.00 | 1.58 | 0.28 |
| Net Profit / Share (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.43 |
| PBDIT Margin (%) | 5.25 | 4.55 | 6.33 | 6.39 | 6.97 |
| PBIT Margin (%) | 4.53 | 4.00 | 5.70 | 5.73 | 5.37 |
| PBT Margin (%) | 0.39 | 1.78 | 1.99 | 1.84 | 0.53 |
| Net Profit Margin (%) | 0.22 | 1.21 | 1.39 | 1.25 | 0.81 |
| Return on Networth / Equity (%) | 1.14 | 10.37 | 8.75 | 7.43 | 8.58 |
| Return on Capital Employeed (%) | 16.17 | 22.87 | 23.95 | 23.85 | 16.73 |
| Return On Assets (%) | 0.25 | 2.41 | 2.12 | 1.65 | 0.85 |
| Long Term Debt / Equity (X) | 0.42 | 0.47 | 0.47 | 0.40 | 0.64 |
| Total Debt / Equity (X) | 2.25 | 1.71 | 1.86 | 2.10 | 3.99 |
| Asset Turnover Ratio (%) | 1.18 | 2.13 | 1.54 | 1.88 | 1.20 |
| Current Ratio (X) | 1.19 | 1.23 | 1.23 | 1.17 | 1.17 |
| Quick Ratio (X) | 0.32 | 0.28 | 0.30 | 0.42 | 0.40 |
| Inventory Turnover Ratio (X) | 1.98 | 3.54 | 2.37 | 3.08 | 1.82 |
| Interest Coverage Ratio (X) | 1.27 | 2.05 | 1.71 | 1.64 | 1.44 |
| Interest Coverage Ratio (Post Tax) (X) | 1.05 | 1.55 | 1.38 | 1.32 | 1.17 |
| Enterprise Value (Cr.) | 66.75 | 85.41 | 60.02 | 67.20 | 14.08 |
| EV / Net Operating Revenue (X) | 0.85 | 0.66 | 0.70 | 0.92 | 0.61 |
| EV / EBITDA (X) | 16.27 | 14.65 | 11.12 | 14.41 | 8.76 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| Price / BV (X) | 2.30 | 4.05 | 2.65 | 3.42 | 2.43 |
| Price / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| EarningsYield | 0.00 | 0.02 | 0.03 | 0.02 | 0.03 |
After reviewing the key financial ratios for Axel Polymers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 2.65 (Mar 24) to 0.86, marking a decrease of 1.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 91.68. It has decreased from 150.19 (Mar 24) to 91.68, marking a decrease of 58.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.82. This value is within the healthy range. It has decreased from 6.84 (Mar 24) to 4.82, marking a decrease of 2.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.16. This value is within the healthy range. It has decreased from 6.02 (Mar 24) to 4.16, marking a decrease of 1.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 2.68 (Mar 24) to 0.36, marking a decrease of 2.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For PBDIT Margin (%), as of Mar 25, the value is 5.25. This value is below the healthy minimum of 10. It has increased from 4.55 (Mar 24) to 5.25, marking an increase of 0.70.
- For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.00 (Mar 24) to 4.53, marking an increase of 0.53.
- For PBT Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 10. It has decreased from 1.78 (Mar 24) to 0.39, marking a decrease of 1.39.
- For Net Profit Margin (%), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has decreased from 1.21 (Mar 24) to 0.22, marking a decrease of 0.99.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 10.37 (Mar 24) to 1.14, marking a decrease of 9.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 22.87 (Mar 24) to 16.17, marking a decrease of 6.70.
- For Return On Assets (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to 0.25, marking a decrease of 2.16.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.42, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 1. It has increased from 1.71 (Mar 24) to 2.25, marking an increase of 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.18. It has decreased from 2.13 (Mar 24) to 1.18, marking a decrease of 0.95.
- For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.19, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.32, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.98. This value is below the healthy minimum of 4. It has decreased from 3.54 (Mar 24) to 1.98, marking a decrease of 1.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 3. It has decreased from 2.05 (Mar 24) to 1.27, marking a decrease of 0.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 24) to 1.05, marking a decrease of 0.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.75. It has decreased from 85.41 (Mar 24) to 66.75, marking a decrease of 18.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.85, marking an increase of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 16.27. This value exceeds the healthy maximum of 15. It has increased from 14.65 (Mar 24) to 16.27, marking an increase of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 4.05 (Mar 24) to 2.30, marking a decrease of 1.75.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Axel Polymers Ltd:
- Net Profit Margin: 0.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.17% (Industry Average ROCE: 16.3%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 12.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.32
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.4 (Industry average Stock P/E: 32.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Plastic & Plastic Products | S.No.309, VIL Mokshi, Sankarda-Savli Road, Vadodra District Gujarat 391780 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gaurav Thanky | Chairman & Managing Director |
| Mrs. Dhara Gaurav Thanky | Non Executive Woman Director |
| Mr. Chirag Shah | Addnl.Non Exe.Independent Director |
| Mr. Ashok Shah | Addnl.Non Exe.Independent Director |
FAQ
What is the intrinsic value of Axel Polymers Ltd?
Axel Polymers Ltd's intrinsic value (as of 24 January 2026) is ₹4.64 which is 89.76% lower the current market price of ₹45.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹38.6 Cr. market cap, FY2025-2026 high/low of ₹60.0/27.7, reserves of ₹6.71 Cr, and liabilities of ₹66.09 Cr.
What is the Market Cap of Axel Polymers Ltd?
The Market Cap of Axel Polymers Ltd is 38.6 Cr..
What is the current Stock Price of Axel Polymers Ltd as on 24 January 2026?
The current stock price of Axel Polymers Ltd as on 24 January 2026 is ₹45.3.
What is the High / Low of Axel Polymers Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Axel Polymers Ltd stocks is ₹60.0/27.7.
What is the Stock P/E of Axel Polymers Ltd?
The Stock P/E of Axel Polymers Ltd is 25.4.
What is the Book Value of Axel Polymers Ltd?
The Book Value of Axel Polymers Ltd is 17.9.
What is the Dividend Yield of Axel Polymers Ltd?
The Dividend Yield of Axel Polymers Ltd is 0.00 %.
What is the ROCE of Axel Polymers Ltd?
The ROCE of Axel Polymers Ltd is 7.88 %.
What is the ROE of Axel Polymers Ltd?
The ROE of Axel Polymers Ltd is 1.13 %.
What is the Face Value of Axel Polymers Ltd?
The Face Value of Axel Polymers Ltd is 10.0.